Warner Chilcott Takes Aim At Lupin's Generic Generess Fe

Law360, New York (December 13, 2011, 6:06 PM EST) -- Warner Chilcott Co. LLC sued Lupin Ltd. in New Jersey federal court Monday, alleging Lupin's proposed generic version of the chewable oral contraceptive Generess Fe infringes a Warner Chilcott patent.

According to the suit, Lupin notified Warner Chilcott in October of its plans for a generic version of the contraceptive.

Warner Chilcott claims Lupin's abbreviated new drug application infringes its patent. It is seeking a court order that Lupin will not be able to market its generic version until the expiration date of the patent, which...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.